The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2021 | COVID-19 vaccination in CLL
Mazyar Shadman, MD, Fred Hutchinson Cancer Research Center, Seattle, WA, talks on COVID-19 vaccine recommendations for patients with chronic lymphocytic leukemia (CLL), highlighting potential efficacy limitations associated with disease biology. Dr Shadman also gives an overview of existing data on COVID-19 vaccine efficacy in patients with CLL and shares recommendations for vaccination. This interview took place at the virtual European Hematology Association (EHA) Congress 2021.
